Home/Filings/4/0001493152-20-012575
4//SEC Filing

Mohan Pankaj 4

Accession 0001493152-20-012575

CIK 0001106838other

Filed

Jul 1, 8:00 PM ET

Accepted

Jul 2, 6:20 PM ET

Size

6.7 KB

Accession

0001493152-20-012575

Insider Transaction Report

Form 4
Period: 2020-07-02
Mohan Pankaj
DirectorChairman, President and CEO
Transactions
  • Award

    Common Stock

    2020-07-02+319,866322,266 total
Holdings
  • Common Stock

    (indirect: By Children)
    7,992
  • Common Stock

    (indirect: By Mohan Family Office)
    930,705
Footnotes (2)
  • [F1]On July 2, 2020, the Reporting Person was granted 319,866 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units vest as to 50% of the restricted stock units on April 2, 2021 and 50% of the restricted stock units on April 2, 2022.
  • [F2]Reporting Person jointly exercises dispositive and voting power over the securities owned by the Mohan Family Office.

Documents

1 file

Issuer

Sonnet BioTherapeutics Holdings, Inc.

CIK 0001106838

Entity typeother

Related Parties

1
  • filerCIK 0001664386

Filing Metadata

Form type
4
Filed
Jul 1, 8:00 PM ET
Accepted
Jul 2, 6:20 PM ET
Size
6.7 KB